Humalog Mix50/50 | Insulin Lispro Injection, Suspension while Breastfeeding
It is recommended to breastfeed exclusively for six months and then while introducing to other food sources extend it to twelve months. In this duration most mothers will need help of some sort of medication, It could be for short term like could and flue or it could be something chronic like Arthritis or Diabetes and here comes the question of safety of medication in use. In this post we will figure out what is Humalog Mix50/50 | Insulin Lispro Injection, Suspension and whether its safe to use Humalog Mix50/50 | Insulin Lispro Injection, Suspension while nursing or not.

What is Humalog Mix50/50 | Insulin Lispro Injection, Suspension used for?


HUMALOG Mix50/50 is indicated to improve glycemic control in patients with diabetes mellitus. HUMALOG® Mix50/50™ is a mixture of insulin lispro protamine, an intermediate-acting human insulin analog, and insulin lispro, a rapid-acting human insulin analog indicated to improve glycemic control in patients with diabetes mellitus. (1) Limitations of Use: The proportions of rapid-acting and intermediate-acting insulins are fixed and do not allow for basal versus prandial dose adjustments. (1) Limitations of Use: The proportions of rapid-acting and intermediate-acting insulins in HUMALOG Mix50/50 are fixed and do not allow for basal versus prandial dose adjustments.

Is Humalog Mix50/50 | Insulin Lispro Injection, Suspension safe to use while breastfeeding? Can it interfere with growth and development of my kid?

Humalog Mix50/50 | Insulin Lispro Injection, Suspension safe for breastfeeding
As per our analysis Humalog Mix50/50 | Insulin Lispro Injection, Suspension contains only one ingredient and that is Insulin lispro. We have analyzed Insulin lispro and it seems to be safe to use Insulin lispro while breastfeeding, that means usage of Humalog Mix50/50 | Insulin Lispro Injection, Suspension shall be safe while breastfeeding. Below you can check more details of Insulin lispro usage in breastfeeding. We recommend you to go through provided detailed analysis as below take decision accordingly.

Humalog Mix50/50 | Insulin Lispro Injection, Suspension Breastfeeding Analsys


Insulin lispro while Breastfeeding

Safe

CAS Number: 8063-29-4

Insulin is a component present in breast milk that helps to lower the risk for Diabetes Mellitus Type I among breastfed infants. A small quantity of insulin is absorbed orally which is a factor that promotes maturation of the intestine, induces glucose tolerance and prevents development of Diabetes type 1. Insulin requirements decrease about 25% after birth in diabetic mothers who breastfeed their babies. Those mothers are in need of higher self-control of disease, and, higher caloric intake is required (500 to 800 kcal/day). Attachment and nursing should be started as soon as possible since second stage of Lactogenesis may be delayed in diabetic mothers. Diabetic mothers who breastfeed would attain a better metabolic control of the disease while breastfeeding.


Humalog Mix50/50 | Insulin Lispro Injection, Suspension Breastfeeding Analsys - 2


Insulin lispro while Breastfeeding

CAS Number: 11061-68-0

Is Humalog Mix50/50 | Insulin Lispro Injection, Suspension safe while breastfeeding

Mothers with diabetes using insulin may nurse their infants.[1] Exogenous insulin is excreted into breastmilk, including newer biosynthetic insulins (e.g., aspart, glargine glulisine, lispro). Insulin is a normal component of breastmilk and may decrease the risk of type 1 diabetes in breastfed infants.[2][3][4] Pasteurization of milk by the Holder method reduces the concentration of insulin by about half.[5] Insulin requirements are reduced postpartum in women with type 1 diabetes.[1][6] In one study, insulin requirements were lower than prepregnancy dosage only during the first week postpartum: 54% of prepregnancy dosage on day 2 and 73% on day 3 postpartum. On day 7 postpartum, insulin dosage returned to prepregnancy requirements.[7] Another study found that dosage requirements did not return to normal for up to 6 weeks in some mothers.[8] A third study found that at 4 months postpartum, patients with type 1 diabetes who exclusively breastfed had an average of 13% lower (range -52% to +40%) insulin requirement than their prepregnancy requirement.[9] A retrospective case-control study found a 34% decrease in postpartum insulin requirement compare to preconception values. There was a nonsignificant trend towards lower requirements in exclusively breastfeeding mothers compared to partial or full formula feeding.[6] Breastfeeding appears to improve glucose postpartum glucose tolerance in mothers with gestational diabetes mellitus[10][11] and in normal women.[12] A small, well-controlled study of women with type 1 diabetes mellitus using continuous subcutaneous insulin found that the average basal insulin requirement in women with type 1 diabetes who breastfed was 0.21 units/kg daily and the total insulin requirement was 0.56 units/kg daily. In similar women who did not breastfeed, the basal insulin requirement was 0.33 units/kg daily and the total insulin requirement was 0.75 units/kg daily. The 36% lower basal insulin requirement was thought to be caused by glucose use for milk production.[13] Lactation onset occurs later in patients with type 1 diabetes than in women without diabetes, with a greater delay in mothers with poor glucose control.[7][14] Mothers with type 1 diabetes also discontinue nursing at a higher rate during the first week postpartum.[15][16][17] Women with any form of diabetes during pregnancy had more problems with low milk supply than women without diabetes.[18] Once established, lactation persists as long in mothers with diabetes as in mothers without diabetes.[14][19] However, as in women without diabetes, smoking has a strong negative impact on lactation among mothers with type 1 diabetes.[9][20] Other factors that have been identified as causes of shorter duration of breastfeeding among type 1 diabetic patients are more frequent caesarean sections and earlier delivery.[21] Among patients with gestational diabetes, those treated with insulin have a delayed onset of lactogenesis II compared to those not treated with insulin.[22]



What if I already have used Humalog Mix50/50 | Insulin Lispro Injection, Suspension?

As usage of Humalog Mix50/50 | Insulin Lispro Injection, Suspension is mostly safe while breastfeeding hence there should not be any concern. In case of any change in behavior or health of your baby you should inform your health care provider about usage of Humalog Mix50/50 | Insulin Lispro Injection, Suspension else no further action is required.


My health care provider has asked me to use Humalog Mix50/50 | Insulin Lispro Injection, Suspension, what to do?

Usage of Humalog Mix50/50 | Insulin Lispro Injection, Suspension is safe for nursing mothers and baby, No worries.


If I am using Humalog Mix50/50 | Insulin Lispro Injection, Suspension, will my baby need extra monitoring?

No


Who can I talk to if I have questions about usage of Humalog Mix50/50 | Insulin Lispro Injection, Suspension in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week

Drug Brands with same Active ingredients